1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Joy Hu
Joy Hu
Articles (296) 

Weekly CEO Buys Highlight

Insiders invest in Cigna, Bausch Health, At Home Group, Aerie Pharmaceuticals and REV Group

September 16, 2019 | About:

According to GuruFocus insider data, these are the largest CEO buys of the past week.

Cigna CEO bought 32,509 shares

Cigna Corp. (NYSE:CI) President and CEO David Cordani bought 32,509 shares on Sept. 9 for an average price of $155.17. The share price has increased by 3.66% since then.

Cigna is one of the largest managed-care organizations in the U.S., with a little over 14 million medical members. It provides health insurance services to individuals mainly through the group (employer) market The company has a market cap of $60.74 billion. Its shares traded at $160.85 with a price-earnings ratio of 13.88 as of Sept. 13.

Net income for the second quarter was $1.41 billion, up from $808 million in the prior-year quarter.

Bausch Health Companies CEO bought 30,000 shares

Bausch Health Companies Inc. (NYSE:BHC) Chairman and CEO Joseph C. Papa bought 30,000 shares on Sept. 13 for an average price of $23.31. The stock has declined 0.3% since then.

Formerly known as Valeant Pharmaceuticals, Bausch Health Companies is a global specialty pharmaceutical company with a focus on branded products for the dermatology, gastrointestinal and ophthalmology markets. The company also has a branded generics business that operates primarily in Latin America, Eastern Europe and Asia. The company has a market cap of $8.20 billion. Its shares traded at $23.24 as of Sept. 13.

Net loss for the three months ended June 30 was $171 million, compared to a net loss of $873 million for the same period in 2018.

Mark C. McKenna, the CEO of Prometheus Biosciences Inc. and former president of Salix, sold 10,773 shares on Aug. 19 for an average price of $21.83. The share price has gained 6.46% since then.

At Home Group CEO bought 64,005 shares

At Home Group Inc. (NYSE:HOME) Chairman, CEO and President Lewis L. Bird III bought 64,005 shares on Sept. 9 for an average price of $7.81. Since then, the share price has climbed 17.93%.

At Home is a home decor superstore. The company provides an assortment of products for every room in every style at everyday low prices. The company has a market cap of $590.16 million. Its shares traded at $9.21 with a price-earnings ratio of 9.38 as of Sept. 13.

Net income for the second quarter of fiscal 2020 was $10.38 million, down from a net loss of $10.07 million for the year-ago quarter.

Chief Financial Officer Jeffrey R. Knudson bought 10,000 shares on Sept. 9 for an average price of $7.89. The stock has advanced 16.73% since then.

Chief Development Officer Norman E. McLeod bought 4,000 shares on Sept. 10 for an average price of $7.99. The share price has increased by 15.27% since then.

President and Chief Operating Officer Peter S. G. Corsa bought 6,393 shares on Sept. 9 for an average price of $7.86. Since then, the stock has risen 17.18%.

Director Philip L. Francis bought 21,125 shares on Sept. 9 for an average price of $7.84. The stock has gained 17.47% since then.

Clifford Sosin, 10% owner, bought 85,000 shares on Sept. 3 for an average price of $6.55 and 240,278 shares on Sept. 5 for an average price of $6.08. The stock has gained 51.48% since then.

Aerie Pharmaceuticals CEO bought 26,250 shares

Aerie Pharmaceuticals Inc. (NASDAQ:AERI) CEO Vicente Anido Jr. bought 26,250 shares on Sept. 9 for an average price of $19.01. The stock has climbed 16.2% since then.

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing therapies for the treatment of patients with glaucoma and other eye diseases. Its main products are Rhopressa and Roclatan. The company has a market cap of $1.02 billion. Its shares traded at $22.09 as of Sept. 13.

The net loss was $47.2 million for the second quarter, an improvement from a net loss of $55 million in the comparable prior-year quarter.

Chief Financial Officer Richard J. Rubino bought 5,040 shares on Sept. 9 for an average price of $19.93. The share price has increased by 10.84% since then.

Foresite Capital Fund II L.P., 10% owner, bought 153,847 shares on Aug. 20 for an average price of $23.88; 46,153 shares on Aug. 23 for an average price of $23.45; 75,000 shares on Sept. 3 for an average price of $21; and 115,900 shares on Sept. 5 for an average price of $18.47.

REV Group CEO bought 50,000 shares

REV Group Inc. (NYSE:REVG) CEO Timothy W. Sullivan bought 50,000 shares on Sept. 10 for an average price of $9.58. The stock has advanced 11.17% since then.

REV Group is a designer, manufacturer and distributor of specialty vehicles and related aftermarket parts and services. It serves a diversified customer base in the U.S. through three segments: Fire and Emergency, Commercial and Recreation. The company has a market cap of $662.51 million. Its shares traded at $10.65 as of Sept. 13.

Net income for the third quarter of 2019 was $5.6 million, compared to $18.3 million in the year-ago quarter.

For the complete list of stocks bought by company CEOs, go to CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by Joy Hu


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)